Amaia Ugarte

1.7k total citations
32 papers, 660 citations indexed

About

Amaia Ugarte is a scholar working on Rheumatology, Psychiatry and Mental health and Clinical Psychology. According to data from OpenAlex, Amaia Ugarte has authored 32 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Rheumatology, 10 papers in Psychiatry and Mental health and 5 papers in Clinical Psychology. Recurrent topics in Amaia Ugarte's work include Systemic Lupus Erythematosus Research (18 papers), Bipolar Disorder and Treatment (9 papers) and Schizophrenia research and treatment (5 papers). Amaia Ugarte is often cited by papers focused on Systemic Lupus Erythematosus Research (18 papers), Bipolar Disorder and Treatment (9 papers) and Schizophrenia research and treatment (5 papers). Amaia Ugarte collaborates with scholars based in Spain, United States and France. Amaia Ugarte's co-authors include Guillermo Ruiz‐Irastorza, Ioana Ruiz‐Arruza, Álvaro Danza, Ana González‐Pinto, Estibaliz Lazaro, Christophe Richez, Patrick Blanco, J.J. Zarranz, Elena Lezcano and Jesús Saavedra‐Lozano and has published in prestigious journals such as PLoS ONE, Movement Disorders and Psychiatry Research.

In The Last Decade

Amaia Ugarte

32 papers receiving 637 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amaia Ugarte Spain	13	351	187	156	117	114	32	660
Emmanuelle Vincent France	8	240 0.7×	286 1.5×	169 1.1×	187 1.6×	133 1.2×	12	1.0k
Sik Nin Wong China	9	195 0.6×	142 0.8×	37 0.2×	49 0.4×	52 0.5×	11	580
Killian O’Rourke Ireland	17	121 0.3×	116 0.6×	156 1.0×	95 0.8×	217 1.9×	42	1.1k
Steven A. Older United States	10	189 0.5×	167 0.9×	34 0.2×	60 0.5×	100 0.9×	14	625
Edward J. Pisko United States	14	266 0.8×	101 0.5×	45 0.3×	42 0.4×	44 0.4×	34	700
Hui Jin Chiew Singapore	9	143 0.4×	94 0.5×	85 0.5×	43 0.4×	23 0.2×	18	378
Carmen Vélez United States	9	105 0.3×	67 0.4×	120 0.8×	122 1.0×	216 1.9×	18	434
Rik Joos Belgium	15	392 1.1×	139 0.7×	17 0.1×	45 0.4×	53 0.5×	29	608
Diana Ernst Germany	13	61 0.2×	76 0.4×	60 0.4×	30 0.3×	48 0.4×	62	691
Erdal Diri United States	10	211 0.6×	33 0.2×	33 0.2×	48 0.4×	47 0.4×	13	551

Countries citing papers authored by Amaia Ugarte

Since Specialization

Citations

This map shows the geographic impact of Amaia Ugarte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amaia Ugarte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amaia Ugarte more than expected).

Fields of papers citing papers by Amaia Ugarte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amaia Ugarte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amaia Ugarte. The network helps show where Amaia Ugarte may publish in the future.

Co-authorship network of co-authors of Amaia Ugarte

This figure shows the co-authorship network connecting the top 25 collaborators of Amaia Ugarte. A scholar is included among the top collaborators of Amaia Ugarte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amaia Ugarte. Amaia Ugarte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jesús, Guilherme Ramires de, Ricard Cervera, Lanlan Ji, et al.. (2022). Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (‘Registry’). Lupus Science & Medicine. 9(1). e000633–e000633. 23 indexed citations

Espinosa, Gerard, María Galindo-Izquierdo, M. Casellas, et al.. (2020). Pregnancy control in patients with systemic lupus erythematosus and antiphospholipid syndrome. Part 1: Infertility, ovarian preservation and preconception assessment. Consensus Document of the Spanish Society of Gynaecology and Obstetrics (SEGO), the Spanish Society of Internal Medicine (SEMI) and the Spanish Society of Rheumatology (SER). Reumatología Clínica (English Edition). 17(2). 61–66. 6 indexed citations

Sáez-Comet, Luís, M. Casellas, Amaia Ugarte, et al.. (2020). Pregnancy control in patients with systemic lupus erythematosus/antiphospholipid syndrome. Part 2: Pregnancy follow-up. Reumatología Clínica (English Edition). 17(3). 125–131. 8 indexed citations

Ruiz‐Irastorza, Guillermo, et al.. (2020). Second week methyl-prednisolone pulses improve prognosis in patients with severe coronavirus disease 2019 pneumonia: An observational comparative study using routine care data. PLoS ONE. 15(9). e0239401–e0239401. 49 indexed citations

Espinosa, Gerard, María Galindo-Izquierdo, M. Casellas, et al.. (2019). Control del embarazo en pacientes con lupus eritematoso sistémico y síndrome antifosfolípido. Parte 1: Infertilidad, preservación ovárica y valoración preconcepcional. Documento de consenso de la Sociedad Española de Ginecología y Obstetricia (SEGO), Sociedad Española de Medicina Interna (SEMI) y Sociedad Española de Reumatología (SER). Reumatología Clínica. 17(2). 61–66. 8 indexed citations

Sáez-Comet, Luís, M. Casellas, Amaia Ugarte, et al.. (2019). Control del embarazo en pacientes con lupus eritematoso sistémico/síndrome antifosfolípido. parte 2: seguimiento del embarazo. Reumatología Clínica. 17(3). 125–131. 8 indexed citations

Ruiz‐Irastorza, Guillermo, Estibaliz Lazaro, Ioana Ruiz‐Arruza, et al.. (2019). Prolonged remission in SLE is possible by using reduced doses of prednisone: An observational study from the Lupus-Cruces and Lupus-Bordeaux inception cohorts. Autoimmunity Reviews. 18(9). 102359–102359. 43 indexed citations

Ugarte, Amaia, Álvaro Danza, & Guillermo Ruiz‐Irastorza. (2018). Glucocorticoids and antimalarials in systemic lupus erythematosus: an update and future directions. Current Opinion in Rheumatology. 30(5). 482–489. 55 indexed citations

Zabala, Arantzazu, I. Querejeta, Ana González‐Pinto, et al.. (2017). A Pilot Study of the Usefulness of a Single Olanzapine Plasma Concentration as an Indicator of Early Drug Effect in a Small Sample of First-Episode Psychosis Patients. Journal of Clinical Psychopharmacology. 37(5). 569–577. 16 indexed citations

10.

Ruiz‐Arruza, Ioana, Jesús Saavedra‐Lozano, Iván Cabezas‐Rodríguez, et al.. (2017). Restrictive Use of Oral Glucocorticoids in Systemic Lupus Erythematosus and Prevention of Damage Without Worsening Long‐Term Disease Control: An Observational Study. Arthritis Care & Research. 70(4). 582–591. 63 indexed citations

11.

Ugarte, Amaia, et al.. (2017). Psychoeducational preventive treatment for women at risk of postpartum depression: study protocol for a randomized controlled trial, PROGEA. BMC Psychiatry. 17(1). 13–13. 9 indexed citations

12.

Ruiz‐Irastorza, Guillermo, Amaia Ugarte, Estibaliz Lazaro, et al.. (2017). Repeated pulses of methyl-prednisolone with reduced doses of prednisone improve the outcome of class III, IV and V lupus nephritis: An observational comparative study of the Lupus-Cruces and lupus-Bordeaux cohorts. Autoimmunity Reviews. 16(8). 826–832. 54 indexed citations

13.

González‐Pinto, Ana, et al.. (2016). On line psycho-education: a complementary approach to the treatment of bipolar disorder. International Journal of Integrated Care. 16(6). 305–305. 1 indexed citations

14.

González–Ortega, Itxaso, et al.. (2016). Online psycho-education to the treatment of bipolar disorder: protocol of a randomized controlled trial. BMC Psychiatry. 16(1). 452–452. 10 indexed citations

15.

Alberich, Susana, Sara Barbeito, Itxaso González–Ortega, et al.. (2016). Psychometric properties and validation of a four-item version of the Strauss–Carpenter scale in bipolar disorder. International Journal of Bipolar Disorders. 4(1). 22–22. 4 indexed citations

16.

Legault, Kimberly, Amaia Ugarte, Mark Crowther, & Guillermo Ruiz‐Irastorza. (2016). Prevention of Recurrent Thrombosis in Antiphospholipid Syndrome: Different from the General Population?. Current Rheumatology Reports. 18(5). 26–26. 7 indexed citations

17.

Ruiz‐Arruza, Ioana, et al.. (2015). Comparison of high versus low–medium prednisone doses for the treatment of systemic lupus erythematosus patients with high activity at diagnosis. Autoimmunity Reviews. 14(10). 875–879. 49 indexed citations

18.

Villar, Irama, et al.. (2014). Prevalence and Significance of Persistently Positive Antiphospholipid Antibodies in Women with Preeclampsia. The Journal of Rheumatology. 42(2). 210–213. 2 indexed citations

19.

González‐Pinto, Ana, Sonia Ruiz de Azúa, Berta Ibáñez, et al.. (2010). Can positive family factors be protective against the development of psychosis?. Psychiatry Research. 186(1). 28–33. 40 indexed citations

20.

Gómez‐Esteban, Juan Carlos, J.J. Zarranz, Beatriz Tijero, et al.. (2007). Restless legs syndrome in Parkinson's disease. Movement Disorders. 22(13). 1912–1916. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact